Document Download

Rilvegostomig Plus Trastuzumab-Deruxtecan for Early-Stage Breast Cancer: The I-SPY2.2 Randomized Clinical Trial.

Author / Organization: I-SPY2 Trial Investigators and Advocates, O'Sullivan CC, Kalinsky KM, Yau C, Kulkarni T, Yee D, Wallace AM, Chien AJ, Boughey JC, Elias AD, Nanda R, Isaacs C, Omene C, Stringer-Reasor E, Clark AS, Thomas A, Han HS, Chan N, Williams N, Trivedi MS, Arora M, Vaklavas C, Tseng J, Bommakanti S, Anampa Mesias JD, Zimmer A, Falkson C, Torres ER, Nangia C, Albain KS, Rozenblit M, Zare S, Fazelli S, Chen YY, Huppert LA, Church AL, Beckwith H, Carroll E, Solanki M, Borges VF, Tevis SEA, Chen N, Zeck JC, Kowzun MJ, Sullivan J, Marshall N, Klein ME, Giridhar KV, Acharya-Leon R, Fan B, Walsh EM, Litvak A, Jahan N, McDonald E, Douglas EH, Zena J, Guth A, Johnson K, McGuinness JE, Matsuda K, Shakeri S, Krishnamurthy J, Kang I, Madans A, Feldman S, Johnson M, Katerji H, Ma Y, Matthews JB, Delson AL, LeStage B, Perlmutter J, Petricoin EF, Shatsky RA, Price E, Basu A, Asare AL, Helsten T, McNatt MH, Mukhtar RA, Symmans WF, Borowsky AD, Heshman DL, DeMichele AM, Rugo HS, Hylton NM, van 't Veer LJ, Esserman LJ

File Format PDF (Portable Document Format)
Publication Year 2026
Source Host PubMed Central (pmc.ncbi.nlm.nih.gov)
License / Terms Open Access / Creative Commons

Ready for Immediate Access

Your selected document is ready for instant access with zero mandatory waiting period.

Alternative Options: Download via MainReads Proxy Read Online in PDF.js Viewer Open Source Website »
Linking & Access Policy: MainReads provides direct outbound links to documents and educational resources hosted by original source repositories, universities, and open libraries. Downloads are never made conditional on advertisements or user registrations. If you encounter an inaccessible or broken resource link, please use the Report Broken Link feature on the catalog page.
« Return to Document Detail & Online Reader